Protocol Ledger

NCT06471829 · Phase II · ACTIVE NOT RECRUITING

A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

Interventional Phase II clinical trial protocol NCT06471829 sponsored by H. Lundbeck in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-06-19 Enrollment: 16 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06471829
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)16 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06471829
Protocol FieldVerified Registry Value
NCT IdentifierNCT06471829
Consolidated Lead SponsorH. Lundbeck
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment16 participants (ACTUAL)
Registered Start Date2024-06-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06471829
Hospital Research SiteLocationSite Profile
University of Michigan Rogel Cancer CenterAnn Arbor, MIOpen Hospital Dossier ->
Washington University and Siteman Cancer CenterSaint Louis, MOOpen Hospital Dossier ->
Hospital de La Santa Creu I Sant PauBarcelona, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI